title: Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).
abstract: A population-based survey was conducted to investigate the epidemiology of and antifungal resistance in Spanish clinical strains of filamentous fungi isolated from deep tissue samples, blood cultures, and respiratory samples. The study was conducted in two different periods (October 2010 and May 2011) to analyze seasonal variations. A total of 325 strains were isolated in 29 different hospitals. The average prevalence was 0.016/1,000 inhabitants [corrected]. Strains were identified by sequencing of DNA targets and susceptibility testing by the European Committee for Antimicrobial Susceptibility Testing reference procedure. The most frequently isolated genus was Aspergillus, accounting for 86.3% of the isolates, followed by Scedosporium at 4.7%; the order Mucorales at 2.5%; Penicillium at 2.2%, and Fusarium at 1.2%. The most frequent species was Aspergillus fumigatus (48.5%), followed by A. flavus (8.4%), A. terreus (8.1%), A. tubingensis (6.8%), and A. niger (6.5%). Cryptic/sibling Aspergillus species accounted for 12% of the cases. Resistance to amphotericin B was found in 10.8% of the isolates tested, while extended-spectrum triazole resistance ranged from 10 to 12.7%, depending on the azole tested. Antifungal resistance was more common among emerging species such as those of Scedosporium and Mucorales and also among cryptic species of Aspergillus, with 40% of these isolates showing resistance to all of the antifungal compounds tested. Cryptic Aspergillus species seem to be underestimated, and their correct classification could be clinically relevant. The performance of antifungal susceptibility testing of the strains implicated in deep infections and multicentric studies is recommended to evaluate the incidence of these cryptic species in other geographic areas.
authors.affiliation: National Center for Microbiology, Madrid, Spain. anaalastruey@isciii.es
authors.forename: A
authors.initials: A
authors.lastname: Alastruey-Izquierdo
authors.forename: E
authors.initials: E
authors.lastname: Mellado
authors.forename: T
authors.initials: T
authors.lastname: Peláez
authors.forename: J
authors.initials: J
authors.lastname: Pemán
authors.forename: S
authors.initials: S
authors.lastname: Zapico
authors.forename: M
authors.initials: M
authors.lastname: Alvarez
authors.forename: J L
authors.initials: JL
authors.lastname: Rodríguez-Tudela
authors.forename: M
authors.initials: M
authors.lastname: Cuenca-Estrella
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects / Q000302:isolation & purification; D001483:Base Sequence; D003881:Dermatomycoses / Q000188:drug therapy* / Q000453:epidemiology* / Q000382:microbiology; D025141:Drug Resistance, Fungal; D005658:Fungi / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D005670:Fusarium / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D010407:Penicillium / Q000187:drug effects / Q000302:isolation & purification; D021681:Scedosporium / Q000187:drug effects / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D013030:Spain; D014230:Triazoles / Q000494:pharmacology
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; D000666:Amphotericin B